{
    "xml": "<topic id=\"PHP101223\" outputclass=\"drug\" rev=\"1.15\" type=\"drug\" namespace=\"/drugs/canagliflozin-with-metformin\" basename=\"canagliflozin-with-metformin\" title=\"CANAGLIFLOZIN WITH METFORMIN\">\n<title>CANAGLIFLOZIN WITH METFORMIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_267\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/biguanides/metformin\">Metformin</xref>, <xref format=\"dita\" href=\"#bnf_int_1283\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/canagliflozin\">Canagliflozin</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP34485\" namespace=\"/drugs/canagliflozin\">canagliflozin</xref>, <xref format=\"dita\" href=\"#PHP4161\" namespace=\"/drugs/metformin-hydrochloride\">metformin hydrochloride</xref>.</p>\n<data name=\"vtmid\">28050111000001100</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_387708906\" title=\"Sodium glucose co-transporter 2 inhibitors\">Sodium glucose co-transporter 2 inhibitors</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_709441655\" title=\"Biguanides\">Biguanides</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP101261\" outputclass=\"indicationsAndDose\" rev=\"1.21\" parent=\"/drugs/canagliflozin-with-metformin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;tablet twice daily, dose based on patient's current metformin dose, daily dose of metformin should not exceed 2&#8239;g.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101265\" outputclass=\"renalImpairment\" parent=\"/drugs/canagliflozin-with-metformin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR less than 60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101274\" outputclass=\"nationalFunding\" rev=\"1.11\" parent=\"/drugs/canagliflozin-with-metformin\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (December 2014) that <i>Vokanamet</i>\n<tm tmtype=\"reg\"/> is accepted for restricted use within NHS Scotland in patients with type 2 diabetes mellitus for whom a combination of canagliflozin and metformin is an appropriate choice of therapy.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101223-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/canagliflozin-with-metformin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101281\" title=\"Tablet\" namespace=\"/drugs/canagliflozin-with-metformin/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_267\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/biguanides/metformin\" title=\"Metformin\" count=\"1\" rel=\"link\">Metformin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1283\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/canagliflozin\" title=\"Canagliflozin\" count=\"1\" rel=\"link\">Canagliflozin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP34485\" namespace=\"/drugs/canagliflozin\" title=\"CANAGLIFLOZIN\" count=\"1\" rel=\"link\">CANAGLIFLOZIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP4161\" namespace=\"/drugs/metformin-hydrochloride\" title=\"METFORMIN HYDROCHLORIDE\" count=\"1\" rel=\"link\">METFORMIN HYDROCHLORIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101281\" namespace=\"/drugs/canagliflozin-with-metformin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP101223",
    "outputclass": "drug",
    "rev": "1.15",
    "type": "drug",
    "namespace": "/drugs/canagliflozin-with-metformin",
    "basename": "canagliflozin-with-metformin",
    "title": "CANAGLIFLOZIN WITH METFORMIN",
    "interactants": [
        {
            "id": "bnf_int_267",
            "label": "Metformin"
        },
        {
            "id": "bnf_int_1283",
            "label": "Canagliflozin"
        }
    ],
    "constituents": [
        {
            "id": "PHP34485",
            "label": "canagliflozin"
        },
        {
            "id": "PHP4161",
            "label": "metformin hydrochloride"
        }
    ],
    "vtmid": "28050111000001100",
    "drugClassification": [
        "Sodium glucose co-transporter 2 inhibitors",
        "Biguanides"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs",
                        "html": "Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 tablet twice daily, dose based on patient's current metformin dose, daily dose of metformin should not exceed 2 g.",
                        "html": "<p>1&#8239;tablet twice daily, dose based on patient's current metformin dose, daily dose of metformin should not exceed 2&#8239;g.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.",
                "html": "<p>Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR less than 60 mL/minute/1.73 m2.",
                "html": "<p>Avoid if eGFR less than 60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (December 2014) that Vokanamet is accepted for restricted use within NHS Scotland in patients with type 2 diabetes mellitus for whom a combination of canagliflozin and metformin is an appropriate choice of therapy.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (December 2014) that <i>Vokanamet</i> <tm tmtype=\"reg\"/> is accepted for restricted use within NHS Scotland in patients with type 2 diabetes mellitus for whom a combination of canagliflozin and metformin is an appropriate choice of therapy.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP101281",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_267",
                "label": "Metformin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1283",
                "label": "Canagliflozin",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP34485",
                "label": "CANAGLIFLOZIN",
                "type": "drug"
            },
            {
                "id": "PHP4161",
                "label": "METFORMIN HYDROCHLORIDE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP101281",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}